Results 231 to 240 of about 57,366 (267)

Intranasal Administration for Targeting Neurodegenerative Disorders

The Blood-Brain Barrier (BBB) limits the ability of therapeutic molecules to reach the brain following oral or parenteral administration. The nasal delivery system has the potential to be used for drug delivery due to its ease of administration and increased bioavailability.
Shivendra Mani Tripathi, Sudhanshu Mishra, Rishabha Malviya, Smriti Ojha   +3 more
openaire   +1 more source

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

INTRANASAL ADMINISTRATION OF NITROGLYCERIN

Anesthesiology, 1979
A. B. Hill, C. J. Bowley, M. L. Nahrwold, P. R. Knight, A. R. Tait, M. D. Taylor, M. M. Kirsh, J. K. Denlinger   +7 more
openaire   +1 more source

Intranasal Naloxone Administration. Reply.

The New England journal of medicine, 2021
Rafael, Ortega, Ala, Nozari, William, Baker   +2 more
openaire   +1 more source

Intranasal Administration of Medications

Orthopaedic Nursing, 1992
openaire   +2 more sources

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

INTRANASAL ADMINISTRATION OF LUTEINISING-HORMONE RELEASING FACTOR

The Lancet, 1974
G, Gennser, P, Liedholm
openaire   +2 more sources

Clinical Practice Guideline: Intranasal Medication Administration

Journal of Emergency Nursing, 2018
openaire   +2 more sources

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly